RSV vaccine (Vaxart)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameRSV vaccine (Vaxart)
Drug Alias NameAd-RSVF
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionRespiratory syncytial virus F protein modulators
TargetsRespiratory syncytial virus F protein
Therapy Area/IndicationsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesVaxart Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesVaxart Biosciences Inc
Inactive CompaniesN/A
Active IndicationsRespiratory Syncytial Virus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A